113 related articles for article (PubMed ID: 36736507)
1. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
[TBL] [Abstract][Full Text] [Related]
2. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Ognibene M; De Marco P; Parodi S; Meli M; Di Cataldo A; Zara F; Pezzolo A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742955
[TBL] [Abstract][Full Text] [Related]
4. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
[TBL] [Abstract][Full Text] [Related]
5. Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.
Bonfiglio F; Lasorsa VA; Cantalupo S; D'Alterio G; Aievola V; Boccia A; Ardito M; Furini S; Renieri A; Morini M; Stainczyk S; Westermann F; Paolella G; Eva A; Iolascon A; Capasso M
EBioMedicine; 2023 Jan; 87():104395. PubMed ID: 36493725
[TBL] [Abstract][Full Text] [Related]
6. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
7. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
8. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
Chicard M; Colmet-Daage L; Clement N; Danzon A; Bohec M; Bernard V; Baulande S; Bellini A; Deveau P; Pierron G; Lapouble E; Janoueix-Lerosey I; Peuchmaur M; Corradini N; Defachelles AS; Valteau-Couanet D; Michon J; Combaret V; Delattre O; Schleiermacher G
Clin Cancer Res; 2018 Feb; 24(4):939-949. PubMed ID: 29191970
[No Abstract] [Full Text] [Related]
9. Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.
Das S; Idate R; Cronise KE; Gustafson DL; Duval DL
Mol Cancer Ther; 2019 Aug; 18(8):1460-1471. PubMed ID: 31175136
[TBL] [Abstract][Full Text] [Related]
10. RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for Pediatric Neuroblastoma.
Sun L; Li X; Tu L; Stucky A; Huang C; Chen X; Cai J; Li SC
Cancer Control; 2023; 30():10732748231175017. PubMed ID: 37161925
[TBL] [Abstract][Full Text] [Related]
11. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
12. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Sausen M; Leary RJ; Jones S; Wu J; Reynolds CP; Liu X; Blackford A; Parmigiani G; Diaz LA; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE; Hogarty MD
Nat Genet; 2013 Jan; 45(1):12-7. PubMed ID: 23202128
[TBL] [Abstract][Full Text] [Related]
14. [Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies].
Liu XZ; Li YY; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):836-844. PubMed ID: 33047716
[TBL] [Abstract][Full Text] [Related]
15. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
[TBL] [Abstract][Full Text] [Related]
16. Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
Degli Esposti C; Iadarola B; Maestri S; Beltrami C; Lavezzari D; Morini M; De Marco P; Erminio G; Garaventa A; Zara F; Delledonne M; Ognibene M; Pezzolo A
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915956
[TBL] [Abstract][Full Text] [Related]
17. Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer.
Das R; Kundu S; Laskar S; Choudhury Y; Ghosh SK
DNA Repair (Amst); 2018; 66-67():50-63. PubMed ID: 29747023
[TBL] [Abstract][Full Text] [Related]
18. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
Liang H; Cheung LW; Li J; Ju Z; Yu S; Stemke-Hale K; Dogruluk T; Lu Y; Liu X; Gu C; Guo W; Scherer SE; Carter H; Westin SN; Dyer MD; Verhaak RG; Zhang F; Karchin R; Liu CG; Lu KH; Broaddus RR; Scott KL; Hennessy BT; Mills GB
Genome Res; 2012 Nov; 22(11):2120-9. PubMed ID: 23028188
[TBL] [Abstract][Full Text] [Related]
20. Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
Corallo D; Zanon C; Pantile M; Tonini GP; Zin A; Francescato S; Rossi B; Trevisson E; Pinato C; Monferrer E; Noguera R; Aliño SF; Herrero MJ; Biffi A; Viscardi E; Aveic S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
